Develops blood tests for early cancer detection.
Dec 2025Revenue $2.05M/yrExpenses $5.38M/yr
No trendCash runway ≈ 1.6 years from Jun 2026
Figures by year
When will 20/20 Biolabs be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $2.05M and expenses $5.38M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.05M | $5.38M | −$3.33M |
| Dec 2024 | $1.75M | $7.43M | −$5.68M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.